Delivery Order SPE2DB20D2014-SPE2DB26FA18G
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $65,345.95 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.16 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This competitive, firm fixed-price delivery order was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $16,736.57 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on August 7, 2025, with an ultimate completion date of August 8, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $36,679.66 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract, which is not set aside and was competitively awarded, is scheduled for completion by October 23, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive award, valued at $11,159.05 under a firm fixed-price contract type, is scheduled for completion by August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was...
- The Defense Logistics Agency awarded a delivery order valued at $70,633.45 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) under a firm fixed price contract. This award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a non-set-aside, competitively awarded procurement. The contractor is headquartered in Conshohocken, Pennsylvania, which also serves as the place of performance for this delivery order. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,898.82 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract was awarded to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, which serves as the place of performance, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $34,787.81 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for $9,652.90 to supply Biktarvy 30-120-15 mg tablets (30-count) with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract is classified as a child order under a larger indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a single transaction...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $67,419.80. The contract is scheduled for completion by October 17, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA18GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,400.78 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This order, issued on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a firm fixed price contract with no set-aside designation. The award was competitively procured and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. AmerisourceBergen's federal contracting demonstrates significant capability in fulfilling defense pharmaceutical procurement requirements, with the company serving as a critical vendor for the Defense Health Agency and other federal healthcare systems through flexible contract mechanisms designed to meet ongoing medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.4k | 10/24/25 |